Because of the many potent biological capabilities of the blood granulocytes, and their contact with platelets in various physiologic and pathologic states, a possible interaction between granulocytes and platelets was investigated. Platelets were purified by gel filtration and via a dialysis membrane were separated from suspensions of autologous granulocytes prepared by dextran sedimentation and resuspended in modified Tyrode's buffer. After 20 min at 37 degrees C platelet aggregation was shown to be diminished by such exposure, as compared to the aggregation of platelets incubated with dialysates of buffer only. When granulocytes were stimulated by the addition of 1.1-muM latex spheres as target particles for phagocytes, the dialysate of these cells exhibited greatly enhanced platelet-inhibitory properties. The addition of catalase to the platelets abolished the effect of exposing these cells to the dialysate of resting granulocytes and markedly inhibited the effect of exposing the platelets to the dialysate of phagocytosing granulocytes. Catalase treated with 3-amino-1,2,4-triazole had no platelet-protective capacity. Purified suspensions of lymphocytes released no platelet-inhibitory principle under these experimental conditions. Hydrogen peroxide in the dialysate of granulocytes was measured directly with an assay involving an H2O2-induced decrease in the fluorescence of scopoletin catalyzed by horseradish peroxidase. The dialysate of phagocytosing granulocytes contained 0.86 +/-0.55 nmol H2O2/2.5 X 10 (7) A B S T R A C T Because of the many potent biological capabilities of the blood granulocytes, and their contact with platelets in various physiologic and pathologic states, a possible interaction between granulocytes and platelets was investigated. Platelets were purified by gel filtration and via a dialysis membrane were separated from suspensions of autologous granulocytes prepared by dextran sedimentation and resuspended in modified Tyrode's buffer. After 20 min at 37TC platelet aggregation was shown to be diminished by such exposure, as compared to the aggregation of platelets incubated with dialysates of buffer only. When granulocytes were stimulated by the addition of 1.1-ILM latex spheres as target particles for phagocytes, the dialysate of these cells exhibited greatly enhanced platelet-inhibitory properties. The addition of catalase to the platelets abolished the effect of exposing these cells to the dialysate of resting granulocytes and markedly inhibited the effect of exposing the platelets to the dialysate of phagocytosing granulocytes. Catalase treated with 3-amino-1,2,4-triazole had no platelet-protective capacity. Purified suspensions of lymphocytes released no platelet-inhibitory principle under these experimental conditions.
A B S T R A C T Because of the many potent biological capabilities of the blood granulocytes, and their contact with platelets in various physiologic and pathologic states, a possible interaction between granulocytes and platelets was investigated. Platelets were purified by gel filtration and via a dialysis membrane were separated from suspensions of autologous granulocytes prepared by dextran sedimentation and resuspended in modified Tyrode's buffer. After 20 min at 37TC platelet aggregation was shown to be diminished by such exposure, as compared to the aggregation of platelets incubated with dialysates of buffer only. When granulocytes were stimulated by the addition of 1.1-ILM latex spheres as target particles for phagocytes, the dialysate of these cells exhibited greatly enhanced platelet-inhibitory properties. The addition of catalase to the platelets abolished the effect of exposing these cells to the dialysate of resting granulocytes and markedly inhibited the effect of exposing the platelets to the dialysate of phagocytosing granulocytes. Catalase treated with 3-amino-1,2,4-triazole had no platelet-protective capacity. Purified suspensions of lymphocytes released no platelet-inhibitory principle under these experimental conditions.
Hydrogen peroxide in the dialysate of granulocytes was measured directly with an assay involving an H202-induced decrease in the fluorescence of scopoletin catalyzed by horseradish peroxidase. The dialysate of phagocytosing granulocytes contained 0.86+0.55 nmol H202/2.5 x 107 granulocytes when sampled at 20 min. By an alternate measurement technique in which scopoletin and horseradish peroxidase were present in the dialysate from time zero, the mean amount of H202 in the dialysate reached 4.0±+1.3 nmol/2.5 X 107 granulocytes at 20 min. This discrepancy suggested the consumption of H202, possibly mediated by the granulocytes themselves. This possibility was investigated by the addition of exogenous H202 to the test system. Both granulocytes and platelets enhanced the disappearance of H202 from the dialysate, and the amount consumed was proportional to the amount of H202 added to the system. Glucose oxidase at 12 M U/ml plus glucose in excess resulted in the production of H202 at a rate and final amount comparable to that produced by phagocytosing granulocytes. This mixture, when substituted for phagocytosing granulocytes in the standard dialysis membrane experiment, induced an inhibition of platelet aggregation similar to that caused by the granulocytes.
The observation that the release of H202 by the blood granulocyte influences platelet function suggests a potential role for the granulocyte in the regulation of hemostasis or thrombosis.
INTRODUCTION
The platelet plays the central role in the initial hemostatic response and in the genesis of arterial thrombosis (1) . Many studies have demonstrated interaction of the platelet with other platelets (2) (4) .
Although arterial thrombi are composed primarily of aggregated platelets, they are also rich in granulocytes (5) (6) (7) . Despite intimate contact between these two cell types, almost nothing is known about how they interact. Given the many potent biological functions of the polymorphonuclear leukocyte (PMN),' it would be surprising if it was passive at the site of platelet reactions.
In the course of their phagocytic activity, PMN undergo significant metabolic alterations. These alterations include a respiratory burst (8) , increased hexose monophosphate shunt activity (9), increased NADH oxidase activity (10) , and H202 production (11) . In addition to these intracellular events, phagocytosing granulocytes also release various agents, among which are H202 (12) and 02-, the superoxide radical (13). Baehner et al. have demonstrated that granulocyte-released H202 has the capacity to effect neighboring cells (14) . These workers mixed activated PMN with glucose-6-phosphate dehydrogenase-deficient erythrocytes and observed Heinz body formation attributable to the elaboration and release of H202 by the granulocytes.
We have previously shown that brief exposure of platelets to micromolar concentrations of H202 can cause significant inhibition of platelet function (15, 16) . The present study deals with two questions. First, can granulocytes influence platelet function in vitro? Second, could such an interaction be mediated, at least in part, by granulocytic production of H202 ?
METHODS
Venous blood from normal individuals who had abstained from all medications, including aspirin, for at least 10 days was collected in plastic syringes and mixed immediately (5: 1) with acid citrate anticoagulant (15) (one part 5% Na citrate and one part 2.7% citric acid plus 4 g/100 ml dextrose) in plastic tubes. The blood was centrifuged at 200 g for 10 min at room temperature, and the platelet-rich plasma (PRP) was removed with a siliconized Pasteur pipette.
Platelet purification. The platelets were separated from the PRP by a modification of the gel filtration technique of Tangen et al. (17) . Plexiglas columns, 2.5 X 25 cm, were filled with Sepharose 2B (Pharmacia Fine Chemicals, Inc., Piscataway, N. J., lot 4326) so that the column bed contained 50 ml of the Sepharose gel. The top of the column had a sample applicator whose bottom was a fine nylon mesh; the column base had coarse and fine nylon mesh.
Before each experiment the column was washed three times with 100 ml of eluting buffer. This eluting buffer was a modification of Tyrode's albumin solution and contained 129 mM NaCl, 9 mM Na HCO3, 6 mM dextrose, 11 mM Na citrate, 11 mM Tris, 1 mM KH2PO4, 3 mM KC1, 1 mM MgC12, 2 mM CaCl2, and 5 g/100 ml salt-poor albumin per 'Abbreviations used in this paper: 3-AT, 3-amino-1,2,4-triazole; GFP, gel-filtered platelets; PMN, polymorphonuclear leukocytes; PRP, platelet-rich plasma. 100 ml, which had previously been dialyzed against this same buffer. The final pH was 7.35.
The volume of PRP applied to the top of the column varied from 6 to 10 ml. The PRP was gently layered onto the gel and the run was started. The platelet peak appeared well before the plasma and could easily be detected visually.
All eluants were collected into plastic tubes, and the resultant gel-filtered platelets (GFP) were adjusted to a count of 250,000/mm3 by dilution with fresh eluant buffer.
Apyrase (18) (Fig. 1 ). To each tube of one set was added 0.90 ml of the GFP plus 0.10 ml of the stock catalase solution (see below), to inactivate any H202 formed. Dialysis bags (Fisher Scientific Co., Pittsburgh, Pa.; 1.5 cm inside diameter) were suspended in each tube of GFP. Bags containing 0.55 ml buffer, in tubes 1 and 4 of each set, served as controls for bags containing 0.5 ml leukocyte suspensions plus 0.05 ml buffer (resting leukocytes, tube 2) and bags containing 0.5 ml leukocyte suspension plus 0.05 ml latex particles (activated leukocytes, tube 3). The ratio of latex particles to leukocytes in these studies was 1,000: 1. Additional experiments were run with 0.50 ml of H202 in dialysis bags, likewise placed into 1.0 ml GFP with or without catalase. After a 20-min incubation at 370C, these bags were removed, and aggregation studies were performed on the GFP.
In each group of experiments statistical significance was determined by Student's t test with paired data (22) .
Generation of HO, by glucose/glucose oxidase. The method of Cohen and Hochstein (23) was used to generate various amounts of H202. Glucose oxidase (Sigma Chemical Co.), 1,200 U/ml, was dialyzed overnight against distilled water and then diluted 1: 2,000 with distilled water. Addition of this solution to the modified Tyrode's buffer containing 1.25 mM glucose yielded H202, as described below.
Measurement of hydrogen peroxide. Direct measurement of H202, either produced by stimulated granulocytes or generated by a glucose/glucose oxidase system, was made by assaying the decrease in the fluorescence of scopoletin catalyzed by horseradish peroxidase. This reaction, originally described by Andreae (24) , has been used by Root (25) to determine the rate of release of H202 from activated granulocytes. Fluorescence was determined in an Aminco-Bowman spectrofluorometer (American Instrument Co., Silver Spring, Md.) with an excitation wavelength of 350 nm and an emission wavelength of 460 nm.
Reagents. Disodium ADP (Sigma Chemical Co.) was dissolved in barbital buffer (pH 7.35) at a concentration of 10 mg/100 ml, adjusted to pH 6.8, and frozen in 1-ml aliquots at -40'C. Addition of 30 ,l of this solution to 0.4 ml of GFP yielded a final concentration of 13 1M ADP.
Apyrase (Adenosine-5'-triphosphatase, Sigma Chemical Co., grade 1) had the approximate activities: 5'-ATPase, 1.58 U/mg; 5'-ADPase, 0.57 U/mg, and 5'-AMPase, 0.03 U/mg. Dow latex particles obtained from Pitman-Moore Div., Dow Chemical Co., Indianapolis, Ind., having a uniform diameter of 1.10 ,um in a 10% solid suspension, were dialyzed against 0.9% NaCl and used as target particles for phagocytosis (26) .
Hydrogen peroxide, 30% solution (J. T. Baker Chemical Co., Phillipsburg, N. J.) was diluted in the modified Tyrode's buffer. This was prepared fresh before each experiment and kept at 4°C until used.
Purified lyophilized catalase (Worthington Biochemical
Corp., Freehold, N. J., lot 5651-4), activity 3,000 U/mg, was dissolved in the modified Tyrode's buffer to a concentration of 10,000 U/mI. This solution was made fresh each day and when used was added to GFP to a final concentration of 1,000 U catalase/ml GFP.
3-Amino-1,2,4-triazole (3-AT), (Sigma Chemical Co., lot 122C-0840) was dissolved in modified Tyrode's buffer to a concentration of 1 M. This solution was made fresh each day and when used was added to the GFP to a final concentration of 100 mM.
Scopoletin (Sigma Chemical Co.), 1 mM, in distilled water was stored at 4°C. Peroxidase, type II from horse- 4) , 0.50 ml granulocytes plus 0.05 ml buffer (number 2), or 0.50 ml granulocytes plus 0.05 ml latex particles (number 3), were suspended in 1.0 ml of autologous platelets. In the bottom set of four samples, catalase has been added to the platelet suspension. After 20 min at 37°C, the bags were removed and discarded, and 0.4-ml samples of platelets were removed for aggregation studies. In each set tube 1 was the control for tube 2, and tube 4 was the control for tube 3. For all studies, the aggregating agent was ADP at 13 ,uM final concentration in the platelet suspension. radish (Sigma Chemical Co.), 100-150 purpurogallin U/ml, was made up in distilled water at a concentration of 1.0 mg/ml and was stored at -200 C.
RESULTS
Effect of H.O.. To determine whether H202 could diffuse across a dialysis membrane and significantly alter platelet function, a series of seven experiments was performed. H202, at a concentration of 0.6 mM in modified Tyrode's buffer, was placed in dialysis bags that were then suspended in GFP as described in Methods. After 20 min at 370C there was a pronounced inhibition of ADP-induced aggregation of the platelets in comparison to platelets exposed to buffer only (P < 0.001). This is shown in column A of Fig. 2 .
In a parallel set of seven experiments catalase was added to the GFP, and the above protocol was repeated. As shown in column B of Fig. 2 , catalase abolished the H202 effect (P < 0.001). In the presence of catalase, the aggregation of platelets exposed to H202 was not significantly different from that of platelets exposed to buffer only (P > 0.05).
Effect of granulocyte products. The aggregation of platelets exposed to dialysis bags containing resting granulocytes was significantly different from the aggregation of platelets incubated with bags containing buffer only. The aggregation curves obtained from a typical experiment following the protocol illustrated in Fig. 1 are shown in Fig. 3 . As can be seen (Fig. 3A) Fig. 4 . Whereas resting granulocytes produced some inhibition of aggregation (column A, Fig. 4 , P <0.05), exposure of platelets to bags of activated leukocytes (Fig. 4, column B) produced a striking inhibition of aggregation, significant at the P < 0.001 level. (In numerous trials no effect on platelet aggregation was seen when latex particles alone were placed into bags.)
Since the platelet-inhibitory effect of externally added H202 had been abolished by catalase (Fig. 2) , similar experiments were performed with respect to the plateletinhibitory effects of granulocytes. In the presence of catalase, the aggregation of platelets exposed to resting granulocytes (Fig. 4, column C) was not different from the aggregation of platelets exposed to buffer only (P > 0.05). On the other hand catalase-treated platelets exposed to activated granulocytes (Fig. 4, column D) were significantly protected against the inhibitory effect of such exposure (P <0.001). It must be noted, however, that even in the presence of catalase, there was a residual inhibition of platelet aggregation after exposure to activated granulocytes (P <0.05).
The specificity of catalase as an inhibitor of the granulocyte's effect on platelets was further evaluated by use of the specific catalase antagonist (27), 3-AT. In a series of six consecutive experiments we again demonstrated that catalase diminished the effect of activated granulocytes on platelet aggregation (Fig. 5,  column A) . Addition of 3-AT to the catalase-treated platelets resulted in the reappearance of inhibition of platelet aggregation after exposure to activated granulocytes (Fig. 5 , column B, (P <0.01).
Effect of lymphocyte products. With an identical protocol, purified lymphocytes both with and without latex spheres were studied. The platelets exposed to B. control dialysis bags had a maximum aggregation of 50.8±10.4% (mean+SD); those exposed to lymphocyte-containing bags had maximum aggregation of 50.4 ±+10.8%, and those exposed to lymphocytes plus latex beads had maximum aggregation of 51.2±10.0%.
Quantitation of H*02 production. H202 concentration was measured directly in the dialysate of stimulated granulocytes after a 20-min incubation at 370C, in the absence of platelets. Scopoletin, 4 IM, and horseradish peroxidase, 16 ,ig/ml, were added to the dialysate, and fluorescence was measured. The mean final amount of H202 found in 10 experiments was 0.86+0.55 nmol (Fig. 6) . These measurements were then repeated as a function of time as outlined below.
Scopoletin at a final concentration of 4 /M was added to the granulocyte suspension in a dialysis bag just before the addition of latex particles. The bag was immediately placed into a fluorometer cuvette that contained 2. peroxidase, 16 /Lg/ml, previously warmed to 370C. At regular intervals the bag was removed, and the fluorescence of the scopoletin in the dialysate was determined. The concentration of H202 in the dialysate is shown in Fig. 6 . At the end of the 20-min incubation, the mean amount of H202 in the dialysate had reached 4.0±)1.3 nmol. Resting granulocytes were similarly studied, and within the limits of the sensitivity of the method no reproducible change in fluorescence could be found. Consumption of HsO.. The experiments described in the above two paragraphs revealed a discrepancy in the amount of H202 measured in the dialysate of activated PMN. The final amount was considerably greater when scopoletin and horseradish peroxidase were present in the dialysate. This suggested that some of the H202 produced was disappearing during the course of the 20-min incubation. Could the activated leukocytes themselves be responsible for degradation of H202 ? To answer this question, activated granulocytes in dialysis bags were exposed to either buffer or H202-con- taining solutions, and the H202 consumption was determined by the following equation: H202 consumed = (H202 added + H202 produced) -H202 observed. To control for dilution and the spontaneous disappearance of H202 at each concentration of H202 added, bags containing only buffer were handled similarly. As shown in Fig. 7 , there was an apparent consumption of H202 by the phagocytosing granulocytes. The amount consumed was proportional to the amount of H202 added to the system. Since the platelet is responsive to H202, studies were performed to determine whether this cell can also consume H202, as does the granulocyte. GFP were placed in dialysis bags at a concentration of 200,000/mm3, and the bags were suspended in fluorometer cuvettes containing Krebs-Ringer bicarbonate buffer to which varying amounts of H202 had been added. To control for dilution and spontaneous disappearance of H202, bags containing only buffer were added to cuvettes and handled similarly. The consumption of H202 mediated by platelets was determined by the following equation: H202 consumed = H202 added -H202 observed. (In a series of six experiments no H202 production could be observed from either resting or ADP-aggregated GFP.) The consumption of Ha20 by GFP is shown in Fig. 8 .
Use of HsOs-generating system. H202 was generated by the incubation of various amounts of glucose and glucose oxidase in dialysis bags, and the rate of H202 release was measured in a manner analogous to that used for intact granulocytes. By serial dilution of glucose oxidase in the presence of excess glucose a concentration was selected (0.012 U/ml) that resulted in the production of H202 at both a rate and a final concentration comparable to that produced by intact, activated granulocytes. This mixture of glucose and glucose oxidase was placed in dialysis bags and immediately suspended in tubes containing GFP. Control GFP were exposed to dialysis bags containing only buffer. As shown in Fig. 9 , the exposure of GFP to bags containing glucose plus glucose oxidase resulted in a significant inhibition (P <0.001) of ADP-induced platelet aggregation.
DISCUSSION
The formation of aggregates of platelets at a site of hemorrhage constitutes the primary hemostatic response (28) . In addition aggregates of platelets are the main constituent of arterial thrombi (29) . Therefore, factors that alter platelet function may have profound effects on hemostasis or thrombosis (30) . The experiments reported here are an attempt to define a potential interaction between the platelet and the blood granulocyte, since these cells have the opportunity to make close physical contact with one another under a variety of circumstances. Our results indicate that granulocytes can release a factor or factors capable of crossing a dialysis membrane and inhibiting the platelet aggregation response.
Phagocytosing granulocytes were shown to exert a marked inhibitory effect on platelet function, while rest-7.0o 
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ing granulocytes had a small but significant inhibitory effect. The latter may simply reflect the inability to prepare a truly "resting" population of granulocytes. Treatment of GFP with catalase abolished the inhibitory -effect of resting granulocytes, but did not completely block the inhibitory effect of activated granulocytes. The inhibitory activity attributable to activated granulocytes in the presence of catalase was still significant (P <0.05 when compared to GFP in the absence of catalase. The inability of catalase to completely block the effects of phagocytosing granulocytes could be due to the elaboration of additional inhibitory factors by the granulocyte. For example, stimulated granulocytes release superoxide into the surrounding medium (13) . Studies are in progress to determine whether superoxide has a direct effect on platelet function. An alternative explanation for the inability of catalase to eliminate completely the inhibitory effects of phagocytosing granulocytes is that platelets may successfully compete with catalase for the available H202.
The specificity of the catalase effect was shown by the experiments with 3-AT, which specifically inhibits the degradation of H202 by catalase (27) . In the presence of 3-AT there is a significant decrease in the action of catalase as an inhibitor of leukocyte-platelet interaction. This is further evidence that the inhibitory principle released is, at least in part, hydrogen peroxide.
As a further control for these experiments, GFP were exposed to dialysis bags containing autologous lymphocytes with or without latex particles. These cells FIGURX 9 Effect of a cell-free H202-generating system on platelet function. Glucose oxidase at 0.012 U/ml and excess glucose, when placed in a dialysis bag, release H202 into the dialysate at a rate and final concentration analogous to phagocytosing granulocytes. In an experiment analogous to that in Fig. 3 , aggregation after exposure to such bags (column B) was inhibited, as compared to the aggregation seen after exposure to bags of buffer only (column A vs. column B, P < 0.01).
did not affect platelet physiology under these experimental conditions. If H202 is the major diffusable platelet-inhibitory factor elaborated by activated granulocytes, it should have been possible to mimic the phenomenon with a cellfree H202-generating system. This first required determination of the amount of granulocyte-produced H202 actually diffusing across the dialysis membrane. We found a mean concentration of 0.86 nmol H202 in the 2.5-ml dialysate of activated granulocytes after a 20-min incubation (Fig. 6 ). Since this was considerably lower than expected from the kinetic measurement of H202 generation by activated granulocytes (25), we determined the rate of appearance of H202 in the dialysate. Granulocyte-produced H202 diffused across the dialysis membrane at a fairly steady rate over the 20-min incubation period. This rate averaged 0.20 nmol/ min/2.5 X 107 granulocytes and yielded a final H202 concentration of 4.0 nmol/2.5 ml in our experimental system.
The difference between the appearance of H202 in the dialysate of stimulated PMIN when monitored continuously (4.0 nmol) and that observed by analyzing the dialysate at 20 min (0.86 nmol) indicates either degradation or consumption of the generated H202.
Granulocyte-Produced H3O0 and Platelet Reactions Since H202 was shown to be consumed by the activated PMN, our value of 0.86 nmol in the dialysate of activated PMN after a 20-min incubation reflects only that H202 generated but not subsequently consumed by the PMN. In addition to PMN, GFP were present in the experimental set-up described in Fig. 1 . These cells were also found to have the capacity to consume H202. Again, the consumption appeared to be related to the initial concentration of H202 surrounding the GFP.
Knowing the rate and amount of H202 diffusing from the dialysis bag of phagocytosing granulocytes, we could now design a simple H202-generating system of corresponding rate and concentration. An appropriate concentration of glucose-glucose oxidase was substituted for granulocytes (Fig. 9) , and this mixture was capable of causing significant inhibition of platelet aggregation when H202 was generated at a rate comparable to that produced by phagocytosing granulocytes. It must be noted that this effect was less intense than that seen after exposure to intact granulocytes.
Our previous studies on the addition of single doses of H202 to platelet suspensions had led us to believe that considerably higher doses of H202 than those measured here were necessary to alter platelet function. When added as a single dose, a minimum concentration of 20 ,MM H202 was necessary (15) . However, when H202 was generated continuously, from either activated PMN or glucose oxidase plus glucose, much lower concentrations were capable of altering platelet function. At a rate of H202 production of 0.2 nmol/min/2.5 X 107 PMN, the concentration at 20 min would be only 1.6 t&M (4.0 nmol/2.5 ml). This observation on the increased sensitivity of platelets to low levels of constantly generated H202 is in keeping with that of Cohen and Hochstein (23) , who observed an increased oxidation of erythrocyte glutathione and increased osmotic fragility when these cells were exposed to a low-level, steadystate infusion of H202.
In summary, the data presented here indicate that a product or products of blood granulocytes can exert significant effects on platelet-physiology. Moreover, there is clear evidence that granulocyte-produced H202 is responsible for a significant portion of the alteration in platelet function. Biochemical alterations brought about by H202 that might explain the inhibition of platelet function include membrane lipid peroxidation (31) , oxidation of free sulfhydryl groups (23) , and alteration of important soluble aggregating agents released by platelets, such as prostaglandins or their precursor endoperoxides (32, 33) . Such changes might be directly attributable to H202, or they could be brought about by the hydroxyl radical (OH. ) that can be formed from H202 and another granulocyte product, superoxide, in the following reaction (34) : H20 + 02->OH. + OH-+ 02. These various possibilities are now under investigation in our laboratory.
The incorporation of large numbers of granulocytes into freshly formed thrombi has been documented (5). In the organization phase of thrombosis, large numbers of neutrophils invade the surfaces of the thrombus closest to the blood (7). These neutrophils have been assumed to serve only a phagocytic function (6) . Could such activated granulocytes, via liberation of H202 or other potent compounds, inhibit propagation at the thrombus-blood interface? Could granulocytes involved in earlier stages of the initial hemostatic response (35, 36) alter or help to regulate platelet reactions in vivo? In 1966, Harrison et al. (37) showed that varying degrees of contamination of PRP by leukocytes altered the in vitro aggregation response of the platelets. Our findings may explain their observation. Perhaps the loss of platelet function during storage of platelet concentrates is attributable in part to products the granulocytes release in these concentrates.
If the granulocyte can indeed influence the course of hemostasis and thrombosis by modulating platelet function, a new avenue of approach to the therapy of hemorrhagic and thrombotic diseases could conceivably be opened.
